|
Who Is Doing The Study?
Gene Security Network (GSN) has selected Pacific Fertility Center as one of several centers to participate in The IPSO Trial
Why Are We Doing This Study
The purpose of the study is to determine whether PGS - testing of embryos created during IVF for chromosome abnormalities prior to transfer to the uterus - improves pregnancy and implantation rates in patients when compared to patients whose embryos are not tested. PGS will be conducted using 24 Chromosome Aneuploidy Screening with Parental Support from Gene Security Network
Who Is Eligible?
If you meet the criteria below, you may be a candidate for this study. To particupate in this study you must:
-
Be a healthy, pre-menopausal female, 35-42 years of age
-
Have a history of less than 3 consecutive miscarriages and no more than one failed IVF cycle
-
Agree to use Ferring Pharmaceutical products during stimulation
-
Agree to be randomly assigned either the arm of the study receiving PGS (TEST arm) or the arm receiving no additional testing (CONTROL arm)
Additional screening will be conducted to determine if you are eligible to enroll.
What Is The Benefit To The Patient
If you qualify and enroll you will receive discounted IVF medications. If you become pregnant during the study, you will receive a small payment for providing information about your pregnancy and birth. If you are assigned to the TEST arm of the study you will receive free PGS
Questions?
If you are interested in more information about this research study, please contact Pacific Fertility Center at 415-834-3095 or email us at research@pacificfertility.com
For additional information on the clinicaltrials.gov site, click here
| 
